Populations appropriate for diabetes screening with retesting every 3 years

July 19, 2019

Diane Christopher, MD

The USPSTF recommends diabetes screening as part of a cardiovascular risk assessment in asymptomatic adults who are overweight or obese and aged between 40 and 70.

Patients with pyelonephritis

Aymptomatic people with BMI > 25 kg/m² (23 kg/m² if Asian-American)

Age > 45

Children or adolescents with BMI > 85th centile or with additional risk factors

High-risk racial-ethnic background

First-degree relative with T2DM

History of GDM

PCOS

TGs > 250 ml/dL or HDL cholesterol < 35 mg/dL

History of CVD

Inactivity, severe obesity (BMI > 35 kg/m2), acanthosis nigricans

IGT, IFG or prediabetes: restest annualy

BMI = body mass index; CVD = cardiovascular disease; GDM = gestational diabetes; HDL = high-density lipoprotein; IGT = impaired glucose tolerance; IFG = impaired fasting glucose; PCOS = polycystic ovary syndrome; TG = triglycerides; T2DM = type 2 diabetes mellitus

The US Preventive Services Task Force recommends diabetes screening as part of a cardiovascular risk assessment in asymptomatic adults who are overweight or obese and aged between 40 and 70. Individuals with a history of PCOS< GDM, and those of higher-risk racial and ethnic groups should be considered for screening at younger ages and lower body mass indexes.

Populations appropriate for diabetes screening with retesting every 3 years

Nanette Santoro, MD

Diane Christopher, MD